Powell Max Limited (PMAX) vs DNA X, Inc. (SONM)

Powell Max Limited and DNA X, Inc. are both Capital Markets companies. DNA X, Inc. is the larger, with a market value of $3.4M against $1.7M — 2.1× the size. Across the 4 metrics below, Powell Max Limited leads on 2 and DNA X, Inc. on 2.

Valuation

Metric PMAX SONM Capital Markets median
P/E — n/m 14.35
P/S — 0.05 2.07
P/B n/m n/m 1.36
Price to free cash flow — n/m 9.28
EV/EBITDA — 0.35 —
EV/Sales — 0.06 —
Earnings yield — (390.59%) (8.28%)
Free cash flow yield — (355.70%) (1.12%)

Profitability

Metric PMAX SONM Capital Markets median
Gross margin — 0.00% 68.15%
Operating margin — 0.00% 0.00%
Net margin — 0.00% (0.34%)
Free cash flow margin — 0.00% 0.00%
Return on equity — 666.17% 0.00%
Return on assets — (42.11%) 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMAX SONM Capital Markets median
Revenue growth (TTM) — 4.17% 19.72%
EPS growth (last fiscal year) 22.92% 77.74% 16.79%
Revenue growth, 5-year CAGR — (12.89%) 17.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PMAX SONM Capital Markets median
Debt to equity 0.07 0.00 0.07
Current ratio 1.80 0.57 1.51
Net debt to EBITDA 0.67 1.18 (0.03)

Dividend

Metric PMAX SONM Capital Markets median
Dividend yield — — 1.58%
Payout ratio — — 0.19

Size

Metric PMAX SONM Capital Markets median
Market cap 1.65m 3.42m 527.01m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack